Dihydrotachysterol
CAS No. 67-96-9
Dihydrotachysterol ( —— )
产品货号. M33729 CAS No. 67-96-9
Dihydrotachysterol 是维生素 D 的一种合成类似物。Dihydrotachysterol 可用于低钙血症(血液中缺乏钙)和甲状旁腺功能减退症(体内缺乏甲状旁腺激素)的研究。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥426 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Dihydrotachysterol
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Dihydrotachysterol 是维生素 D 的一种合成类似物。Dihydrotachysterol 可用于低钙血症(血液中缺乏钙)和甲状旁腺功能减退症(体内缺乏甲状旁腺激素)的研究。
-
产品描述Dihydrotachysterol is a synthetic analog of vitamin D. Dihydrotachysterol can be used to for the research of hypocalcemia (lack of calcium in the blood) and hypoparathyroidism (lack of parathyroid hormone in the body) .
-
体外实验Dihydrotachysterol is effective in the elevation of serum calcium by stimulating intestinal calcium absorption and mobilizing bone calcium in the absence of parathyroid hormone and of functioning renal tissue. Dihydrotachysterol also increases renal phosphate excretion.
-
体内实验Dihydrotachysterol is a potent synthetic vitamin D analogue that is widely available but more expensive than vitamin D2. It has an onset of action and half-life between those of vitamin D2 and calcitriol. Dihydrotachysterol (initially given at 0.03 to 0.08 mg/kg/day for 2 to 3 days. The final dosages range from 0.004 to 0.04 mg/kg/day) is useful for the treatment of hypoparathyroidism.Animal Model:Animal Model: Five young to middle-aged cats of mixed breeding Dosage:Initially given at a dosage ranging from 0.03 to 0.08 mg/kg/day for 2 to 3 days. The final dosage ranged from 0.004 to 0.04 mg/kg/day.Administration:Oral administration Result:Was useful for the treatment of hypoparathyroidism.
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number67-96-9
-
分子量398.66
-
分子式C28H46O
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESC[C@@]12[C@](\C(=C\C=C/3\[C@@H](C)CC[C@H](O)C3)\CCC1)(CC[C@@]2([C@@H](/C=C/[C@@H](C(C)C)C)C)[H])[H]
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. I Quack, et al. Dihydrotachysterol therapy for hypoparathyroidism: consequences of inadequate monitoring. Five cases and a review. Exp Clin Endocrinol Diabetes. 2005 Jul;113(7):376-80.?
产品手册
关联产品
-
Diethyl succinate
琥珀酸二乙酯是琥珀酸的二乙酯,具有刺激性。
-
CFP10 (71-85)
CFP10 (71-85)
-
Bruceoside A
Bruceoside A could be transformed into the potent anticancer component brusatol in vivo, rather than its direct deglycosylated metabolite bruceosin.
021-51111890
购物车()
sales@molnova.cn

